Latest news
Loading news…
RNAgene
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Songpadong, Seoul-t'ukpyolsi, South Korea Founded 2018 1-10 employees For Profit
RNAgene is a company that focuses on the development of therapeutics based on messenger ribonucleic acid (mRNA).
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
6
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 15
- Patents granted
- 6
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $9M
Company Info
- Founded
- 2018
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- HQ
- Songpadong, Seoul-t'ukpyolsi, South Korea
- Region
- Asia-Pacific (APAC)
Signals & Scores
- Heat score
- Medium
- Growth score
- High
- Trend (7d)
- 0
- Trend (30d)
- -0.5
- Trend (90d)
- -0.1
Key People at RNAgene
Co-Founder & VP
CEO
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to RNAgene
Loading news…
FAQs about RNAgene
People who checked this page also checked these
Browse the full Acquirezy directory.